Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

BIOTCHNO

BIOTCHNO Featured 

Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors

May 24, 2021August 4, 2021 RJ

Webinar will take place Monday April 12, 2021 at 2:00 pm ET Canada NewsWire SAN DIEGO and CALGARY, AB ,

Read more
BIOTCHNO Featured 

Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay

March 31, 2021August 4, 2021 RJ

The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate

Read more
BIOTCHNO General 

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

March 31, 2021July 19, 2021 Raza

Canada NewsWire VANCOUVER, BC, March 31, 2021 /CNW/ – Willow Biosciences Inc. (” Willow ” or the ” Company “) (TSX: WLLW) (OTCQX:

Read more
BIOTCHNO Leaders 

Eisai Awarded The New Diversity Management Selection 100

March 21, 2021August 4, 2021 Raza

TOKYO, Mar 22, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that it was selected as one of

Read more
BIOTCHNO General 

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

February 26, 2021May 17, 2021 Raza

Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine Executive

Read more
BIOTCHNO General Technology 

MindMed Reaches Agreement to Acquire HealthMode

February 19, 2021April 13, 2021 Bachittar

  Canada NewsWire Acquisition will help build a full stack digital mental health platform for psychedelic medicines; Ex-Pfizer Digital Medicine

Read more
BIOTCHNO Technology 

Think Research Sees 633 Per Cent Growth in Demand for VirtualCare Telemedicine Platform

February 19, 2021April 20, 2021 Bachittar

Think Research Sees 633 Per Cent Growth in Demand for VirtualCare Telemedicine Platform During COVID-19 Pandemic Canada NewsWire /NOT FOR

Read more
BIOTCHNO 

SQI Diagnostics Announces New Corporate Website

February 18, 2021April 14, 2021 Bachittar

Canada NewsWire New Website Provides Essential Information on Company’s Strategic Initiative TORONTO, Feb. 18, 2021/CNW/ – SQI Diagnostics Inc. (the

Read more
BIOTCHNO General 

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

February 18, 2021April 8, 2021 Desiree Justice

  Canada NewsWire SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIALVANCOUVER, BC,Feb. 18, 2021/CNW/ — BioVaxys Technology

Read more
BIOTCHNO General 

Neptune Wellness Solutions Inc. Announces Termination of “At-The-Market” Offering

February 17, 2021April 8, 2021 Bachittar

  Canada NewsWire LAVAL, QC,Feb. 17, 2021/CNW Telbec/ – Neptune Wellness Solutions, Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT),

Read more
  • ← Previous

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057